<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39433647</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Neuroinflammation in Severe COVID-19: The Dynamics of Inflammatory and Brain Injury Markers During Hospitalization.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-024-04551-4</ELocationID><Abstract><AbstractText>Patients with COVID-19 can develop excessive inflammation in the brain and consequent neurological complications. The aim of this study was to evaluate the inflammatory, endothelial and brain injury markers in hospitalized COVID-19 patients and compare those with or without neurological symptoms. A total of 30 intensive care unit (ICU) COVID-19 patients were allocated into COVID-19 (without neurological symptoms) or neuro-COVID-19 (with neurological symptoms) groups. Patients with respiratory infection symptoms but negative for COVID-19 were included as a control group. Peripheral blood samples were collected at hospital admission (T1) (controls and ICU patients) and during hospitalization (T2: last 72 h before hospital discharge or in-hospital death) (ICU COVID-19 patients) to analyze inflammatory markers. Higher ICAM-1, CCL26 and VEGF at T1 were identified in both COVID-19 groups compared with control. Neuro-COVID-19 patients presented lower systemic BDNF levels compared with the control group and increased S100B compared with the control and COVID-19 groups. BDNF levels in survivors were lower in the neuro-COVID-19 group compared to the COVID-19 group, while S100B were higher, regardless of the outcome. In addition, all COVID-19 patients presented increased ICAM-1 and CCL26 levels over the hospitalization period (T2 &gt; T1). Furthermore, S100B, ICAM-1, CCL26 and VEGF levels increased in relation to T1 in neuro-COVID-19 patients, with S100B and CCL26 being significantly higher in relation to the COVID-19 group. In conclusion, high levels of brain injury biomarkers were found in patients with neuro-COVID-19, indicating neuroinflammatory and consequent brain injury in the last 72 h of hospitalization.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neves</LastName><ForeName>Carla Andretta Moreira</ForeName><Initials>CAM</Initials><Identifier Source="ORCID">0000-0002-1338-9399</Identifier><AffiliationInfo><Affiliation>Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite 245, Porto Alegre, RS, 90050-170, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorneles</LastName><ForeName>Gilson P</ForeName><Initials>GP</Initials><Identifier Source="ORCID">0000-0001-6524-3204</Identifier><AffiliationInfo><Affiliation>Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite 245, Porto Alegre, RS, 90050-170, Brazil. gilsondorneles@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. gilsondorneles@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Paula C</ForeName><Initials>PC</Initials><Identifier Source="ORCID">0000-0001-7702-3313</Identifier><AffiliationInfo><Affiliation>Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite 245, Porto Alegre, RS, 90050-170, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santana Filho</LastName><ForeName>Paulo C</ForeName><Initials>PC</Initials><Identifier Source="ORCID">0000-0002-1420-7841</Identifier><AffiliationInfo><Affiliation>Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite 245, Porto Alegre, RS, 90050-170, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peres</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3587-2832</Identifier><AffiliationInfo><Affiliation>Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite 245, Porto Alegre, RS, 90050-170, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biosciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeck</LastName><ForeName>Carina Rodrigues</ForeName><Initials>CR</Initials><Identifier Source="ORCID">0000-0002-6828-5634</Identifier><AffiliationInfo><Affiliation>Franciscan University, UFN, Santa Maria, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rotta</LastName><ForeName>Liane N</ForeName><Initials>LN</Initials><Identifier Source="ORCID">0000-0003-1043-5203</Identifier><AffiliationInfo><Affiliation>Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Claudia E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0003-3639-1851</Identifier><AffiliationInfo><Affiliation>Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romão</LastName><ForeName>Pedro R T</ForeName><Initials>PRT</Initials><Identifier Source="ORCID">0000-0002-1039-2509</Identifier><AffiliationInfo><Affiliation>Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite 245, Porto Alegre, RS, 90050-170, Brazil. pedror@ufcspa.edu.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. pedror@ufcspa.edu.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biosciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. pedror@ufcspa.edu.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BDNF</Keyword><Keyword MajorTopicYN="N">CCL26</Keyword><Keyword MajorTopicYN="N">Endothelial injury</Keyword><Keyword MajorTopicYN="N">Inflammatory mediators</Keyword><Keyword MajorTopicYN="N">S100B</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39433647</ArticleId><ArticleId IdType="doi">10.1007/s12035-024-04551-4</ArticleId><ArticleId IdType="pii">10.1007/s12035-024-04551-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P et al (2021) A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology 96(4):e575–e586. https://doi.org/10.1212/WNL.0000000000010979</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010979</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId><ArticleId IdType="pmc">7905791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurol 77(6):683–690. https://doi.org/10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J et al (2022) Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci 434:120162. https://doi.org/10.1016/j.jns.2022.120162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId><ArticleId IdType="pmc">8798975</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderheiden A, Klein RS (2022) Neuroinflammation and COVID-19. Curr Opin Neurobiol 76:102608. https://doi.org/10.1016/j.conb.2022.102608</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2022.102608</ArticleId><ArticleId IdType="pubmed">35863101</ArticleId><ArticleId IdType="pmc">9239981</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, Laffan A, O’Keeffe E, Zaporojan L et al (2024) Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci 27(3):421–432. https://doi.org/10.1038/s41593-024-01576-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId><ArticleId IdType="pmc">10917679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowiański P, Lietzau G, Czuba E, Waśkow M, Steliga A, Moryś J (2018) BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol 38(3):579–593. https://doi.org/10.1007/s10571-017-0510-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-017-0510-4</ArticleId><ArticleId IdType="pubmed">28623429</ArticleId></ArticleIdList></Reference><Reference><Citation>Motaghinejad M, Gholami M (2020) Possible neurological and mental outcomes of COVID-19 infection: a hypothetical role of ACE-2\Mas\BDNF signaling pathway. Int J Prev Med 11:84. https://doi.org/10.4103/ijpvm.IJPVM_114_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijpvm.IJPVM_114_20</ArticleId><ArticleId IdType="pubmed">33042481</ArticleId><ArticleId IdType="pmc">7518341</ArticleId></ArticleIdList></Reference><Reference><Citation>Michetti F, D’Ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E et al (2019) The S100B story: from biomarker to active factor in neural injury. J Neurochem 148(2):168–187. https://doi.org/10.1111/jnc.14574</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14574</ArticleId><ArticleId IdType="pubmed">30144068</ArticleId></ArticleIdList></Reference><Reference><Citation>Thelin EP, Zeiler FA, Ercole A, Mondello S, Büki A, Bellander BM et al (2017) Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review. Front Neurol 8:300. https://doi.org/10.3389/fneur.2017.00300</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00300</ArticleId><ArticleId IdType="pubmed">28717351</ArticleId><ArticleId IdType="pmc">5494601</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahboubi Mehrabani M, Karvandi MS, Maafi P, Doroudian M (2022) Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Rev Med Virol 32(6):e2334. https://doi.org/10.1002/rmv.2334</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2334</ArticleId><ArticleId IdType="pubmed">35138001</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin XX, Zheng XR, Peng W, Wu ML, Mao XY (2020) Vascular endothelial growth factor (VEGF) as a vital target for brain inflammation during the COVID-19 outbreak. ACS Chem Neurosci 11(12):1704–1705. https://doi.org/10.1021/acschemneuro.0c00294</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00294</ArticleId><ArticleId IdType="pubmed">32485101</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui TM, Wiesolek HL, Sumagin R (2020) ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol 108(3):787–799. https://doi.org/10.1002/JLB.2MR0220-549R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.2MR0220-549R</ArticleId><ArticleId IdType="pubmed">32182390</ArticleId></ArticleIdList></Reference><Reference><Citation>Shou J, Peng J, Zhao Z, Huang X, Li H, Li L et al (2019) CCL26 and CCR3 are associated with the acute inflammatory response in the CNS in experimental autoimmune encephalomyelitis. J Neuroimmunol 333:576967. https://doi.org/10.1016/j.jneuroim.2019.576967</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2019.576967</ArticleId><ArticleId IdType="pubmed">31151084</ArticleId></ArticleIdList></Reference><Reference><Citation>Aceti A, Margarucci LM, Scaramucci E, Orsini M, Salerno G, Di Sante G et al (2020) Serum S100B protein as a marker of severity in Covid-19 patients. Sci Rep 10(1):18665. https://doi.org/10.1038/s41598-020-75618-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75618-0</ArticleId><ArticleId IdType="pubmed">33122776</ArticleId><ArticleId IdType="pmc">7596559</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer M, Wille G, Klien S, Shanib H, Holle D, Gaul C, Broessner G (2012) Brain-derived neurotrophic factor in primary headaches. J Headache Pain 13(6):469–475. https://doi.org/10.1007/s10194-012-0454-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10194-012-0454-5</ArticleId><ArticleId IdType="pubmed">22584531</ArticleId><ArticleId IdType="pmc">3464472</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagnato S, Galardi G, Ribaudo F, Boccagni C, Fiorilla TV, Rubino F et al (2020) Serum BDNF levels are reduced in patients with disorders of consciousness and are not modified by verticalization with robot-assisted lower-limb training. Neural Plast 2020:5608145. https://doi.org/10.1155/2020/5608145</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5608145</ArticleId><ArticleId IdType="pubmed">32565776</ArticleId><ArticleId IdType="pmc">7261323</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee CL, Jones KR, Finger TE (2003) Brain-derived neurotrophic factor is present in adult mouse taste cells with synapses. J Comp Neurol 459(1):15–24. https://doi.org/10.1002/cne.10589</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.10589</ArticleId><ArticleId IdType="pubmed">12629664</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean JH, Darby-King A, Bonnell WS (2001) Neonatal olfactory sensory deprivation decreases BDNF in the olfactory bulb of the rat. Brain Res Dev Brain Res 128(1):17–24. https://doi.org/10.1016/s0165-3806(01)00144-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-3806(01)00144-4</ArticleId><ArticleId IdType="pubmed">11356258</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S, Kim L, Whitaker M, O’Halloran A, Cummings C, Holstein R et al (2020) Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1–30. MMWR Morb Mortal Wkly Rep 69(15):458–464. https://doi.org/10.15585/mmwr.mm6915e3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6915e3</ArticleId><ArticleId IdType="pubmed">32298251</ArticleId><ArticleId IdType="pmc">7755063</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323(20):2052–2059. https://doi.org/10.1001/jama.2020.6775</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId><ArticleId IdType="pmc">7177629</ArticleId></ArticleIdList></Reference><Reference><Citation>Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A et al (2020) Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open 3(6):e2012270. https://doi.org/10.1001/jamanetworkopen.2020.12270</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.12270</ArticleId><ArticleId IdType="pubmed">32543702</ArticleId><ArticleId IdType="pmc">7298606</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinot M, Eyriey M, Gravier S, Bonijoly T, Kayser D, Ion C et al (2021) Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients. Infect Dis Now 51(6):518–525. https://doi.org/10.1016/j.idnow.2021.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2021.07.002</ArticleId><ArticleId IdType="pubmed">34242842</ArticleId><ArticleId IdType="pmc">8260549</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E, Giussani G, Westenberg E, Allegri R, Garcia-Azorin D, Guekht A et al (2022) Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions. J Neurol 269(5):2265–2274. https://doi.org/10.1007/s00415-021-10848-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10848-4</ArticleId><ArticleId IdType="pubmed">34674005</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong M, Jiang Y, Xia D, Xiong Y, Zheng Q, Chen F et al (2020) Elevated expression of serum endothelial cell adhesion molecules in COVID-19 patients. J Infect Dis 222(6):894–898. https://doi.org/10.1093/infdis/jiaa349</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa349</ArticleId><ArticleId IdType="pubmed">32582936</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufa A, Gebremariam TH, Manyazewal T, Getinet T, Webb DL, Hellström PM et al (2022) Inflammatory mediators profile in patients hospitalized with COVID-19: a comparative study. Front Immunol 13:964179. https://doi.org/10.3389/fimmu.2022.964179</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.964179</ArticleId><ArticleId IdType="pubmed">35958594</ArticleId><ArticleId IdType="pmc">9359079</ArticleId></ArticleIdList></Reference><Reference><Citation>Morichi S, Morishita N, Takeshita M, Ishida Y, Oana S, Yamanaka G et al (2017) Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) levels in the cerebrospinal fluid of children with influenza-associated encephalopathy. J Infect Chemother 23(2):80–84. https://doi.org/10.1016/j.jiac.2016.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2016.10.007</ArticleId><ArticleId IdType="pubmed">27887787</ArticleId></ArticleIdList></Reference><Reference><Citation>Pino M, Kelvin DJ, Bermejo-Martin JF, Alonso A, Matías V, Tenorio A et al (2009) Nasopharyngeal aspirate cytokine levels 1 yr after severe respiratory syncytial virus infection. Pediatr Allergy Immunol 20(8):791–795. https://doi.org/10.1111/j.1399-3038.2009.00868.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3038.2009.00868.x</ArticleId><ArticleId IdType="pubmed">19302175</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A, Osiaevi I, Buscher K, Sackarnd J, Tepasse PR, Fobker M et al (2021) Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis 24(1):145–157. https://doi.org/10.1007/s10456-020-09753-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-020-09753-7</ArticleId><ArticleId IdType="pubmed">33058027</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J et al (2021) COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis 24(4):755–788. https://doi.org/10.1007/s10456-021-09805-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-021-09805-6</ArticleId><ArticleId IdType="pubmed">34184164</ArticleId><ArticleId IdType="pmc">8238037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pine AB, Meizlish ML, Goshua G, Chang CH, Zhang H, Bishai J (2020) Circulating markers of angiogenesis and endotheliopathy in COVID-19. Pulm Circ 10(4):2045894020966547. https://doi.org/10.1177/2045894020966547</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2045894020966547</ArticleId><ArticleId IdType="pubmed">33282193</ArticleId><ArticleId IdType="pmc">7691906</ArticleId></ArticleIdList></Reference><Reference><Citation>de AzambujaPias Weber A, Viero FT, Pillat MM, de Lima Gonçalves T (2024) Changes in markers of inflammation and their correlation with death in patients with COVID-19 in the intensive care unit. Cytokine 175:156509. https://doi.org/10.1016/j.cyto.2024.156509</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2024.156509</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin R, He L, Yang Z, Jia N, Chen R, Xie J, Fu W, Chen H et al (2022) Identification of parameters representative of immune dysfunction in patients with severe and fatal COVID-19 infection: a systematic review and meta-analysis. Clin Rev Allergy Immunol 64(1):33–65. https://doi.org/10.1007/s12016-021-08908-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08908-8</ArticleId><ArticleId IdType="pubmed">35040086</ArticleId><ArticleId IdType="pmc">8763427</ArticleId></ArticleIdList></Reference><Reference><Citation>Postiga IAL, Teixeira PC, Neves CAM, Santana Filho P, Marmett B, Carvalho R et al (2022) Systemic redox imbalance in severe COVID-19 patients. Cell Biochem Funct 40(7):694–705. https://doi.org/10.1002/cbf.3735</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.3735</ArticleId><ArticleId IdType="pubmed">35980161</ArticleId><ArticleId IdType="pmc">9538604</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiee A, Seighali N, Teymouri Athar M, Abdollahi AK, Jafarabady K, Bakhtiyari M (2023) Levels of brain-derived neurotrophic factor (BDNF) among patients with COVID-19: a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-023-01681-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-023-01681-z</ArticleId><ArticleId IdType="pubmed">37646849</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgarzadeh A, Fouladi N, Asghariazar V, Sarabi SF, Khiavi HA, Mahmoudi M, Safarzadeh E (2022) Serum brain-derived neurotrophic factor (BDNF) in COVID-19 patients and its association with the COVID-19 manifestations. J Mol Neurosci 72(9):1820–1830. https://doi.org/10.1007/s12031-022-02039-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-022-02039-1</ArticleId><ArticleId IdType="pubmed">35749045</ArticleId><ArticleId IdType="pmc">9243868</ArticleId></ArticleIdList></Reference><Reference><Citation>Demir B, Beyazyüz E, Beyazyüz M, Çelikkol A, Albayrak Y (2023) Long-lasting cognitive effects of COVID-19: is there a role of BDNF? Eur Arch Psychiatry Clin Neurosci 273(6):1339–1347. https://doi.org/10.1007/s00406-022-01514-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-022-01514-5</ArticleId><ArticleId IdType="pubmed">36355087</ArticleId></ArticleIdList></Reference><Reference><Citation>Azoulay D, Shehadeh M, Chepa S, Shaoul E, Baroum M, Horowitz NA, Kaykov E (2020) Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration. J Infect 81(3):e79–e81. https://doi.org/10.1016/j.jinf.2020.06.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.038</ArticleId><ArticleId IdType="pubmed">32569603</ArticleId><ArticleId IdType="pmc">7305721</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrella C, Nenna R, Petrarca L, Tarani F, Paparella R, Mancino E et al (2022) Serum NGF and BDNF in long-COVID-19 adolescents: a pilot study. Diagnostics (Basel) 12(5):1162. https://doi.org/10.3390/diagnostics12051162</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12051162</ArticleId><ArticleId IdType="pubmed">35626317</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva RC, da Rosa MM, Leão HI, Silva EDL, Ferreira NT, Albuquerque APB et al (2023) Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil. J Neurovirol 29(2):180–186. https://doi.org/10.1007/s13365-023-01119-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-023-01119-1</ArticleId><ArticleId IdType="pubmed">36719594</ArticleId><ArticleId IdType="pmc">9888322</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin BE, Celikbilek A, Kocak Y, Saltoglu GT, Konar NM, Hizmali L (2022) Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms. J Neurol Sci 439:120324. https://doi.org/10.1016/j.jns.2022.120324</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120324</ArticleId><ArticleId IdType="pubmed">35752131</ArticleId><ArticleId IdType="pmc">9212259</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrettou CS, Vassiliou AG, Pratikaki M, Keskinidou C, Tsipilis S, Gallos P et al (2022) Comparative evaluation and prognostic utility of neuronal injury biomarkers in COVID-19 patients: a prospective study. Shock 58(6):507–513. https://doi.org/10.1097/SHK.0000000000002017</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000002017</ArticleId><ArticleId IdType="pubmed">36548642</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>